Patent · US Expired

Prevention and treatment of amyloidogenic disease

US6787140B1 · kind B1 · utility

77Cited by
79References
43Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 28, 2000
Grant dateSep 7, 2004
Priority date
Expiry dateJun 24, 2021

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/105831
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for treatment of amyloidogenic diseases. Such methods entail administering an agent that induces a beneficial immune response against an amyloid deposit in the patient. The methods are particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease. In such methods, a suitable agent is A&bgr; peptide or an antibody thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.